Designing In-House SARS-CoV-2 RT-qPCR Assay for Variant of Concerns

Abstract

Variants (Alfa, Gamma, Beta, and Delta) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are circulating worldwide. These variants of concerns share some common mutations but they also have distinguishing mutations. These mutations affect transmissibility of virus and cause evasion from neutralizing antibodies. Monitoring and identification of circulating variants is of great importance for public health. In this study, an in-house SARS-CoV-2 reverse transcription quantitative polymerase chain reaction (RT-qPCR) kit was designed to detect variants of concerns by the World Health Organization.

Primer sets and probes were designed to target presence of virus along with mutations for identifying different variants (for N501Y, HV69–70del, K417N, and T478K). Reactions were set by using commercially available master mixes without a reference dye.

The RT-qPCR conditions were optimized by using commercially available ribonucleic acid samples of wild-type, Alfa, Beta, Gamma, and Delta variants. Several samples were also analyzed by the in-house kit after optimization studies. All Alfa variant and wild-type samples were also double confirmed with a commercially available variant detection kit demonstrating a 100% consistence with the in-house kit. Beta, Gamma, and Delta variants could not be confirmed with any other commercially available kits as there is not any available one in the market.

SARS-CoV-2 variants are gaining importance during the pandemic and shaping the fight against the virus. RT-qPCR kits detecting different variants would provide a significant advantage while screening the population.

Keywords

severe acute respiratory syndrome coronavirus 2 - COVID-19 - variant of concerns - reverse transcription quantitative polymerase chain reaction - molecular diagnosis

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Publication History

Article published online:
20 September 2022

• References

• 1 Public Health England Investigation of Novel SARS-CoV-2 Variant: Variant of Concern. Public Health England 2020. Accessed September 17, 2021 at: https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201
• 2 Volz E, Mishra S, Chand M. et al; COVID-19 Genomics UK (COG-UK) consortium. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 2021; 593 (7858): 266-269
• 3 Wang Q, Zhang Y, Wu L. et al. Structural and Functional Basis of SARS-CoV-2 entry by using human ACE2. Cell 2020; 181 (04) 894-904.e9
• 4 Starr TN, Greaney AJ, Hilton SK. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 2020; 182 (05) 1295-1310.e20
• 5 Tegally H, Wilkinson E, Giovanetti M. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. [ Internet ]. Vol. 10. Accessed April 10, 2021 at: https://doi.org/10.1101/2020.12.21.20248640
• 6 Fujino T, Nomoto H, Kutsuna S. et al. Novel SARS-CoV-2 variant in travelers from Brazil to Japan. Emerg Infect Dis 2021; 27 (04) 1243-1245v
• 7 Kemp S, Datir R, Collier D. et al. Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70. bioRxiv [ Internet ]. Accessed May 17, 2021 at: https://doi.org/10.1101/2020.12.14.422555
• 8 Jangra S, Ye C, Rathnasinghe R. et al; Personalized Virology Initiative study group. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe 2021; 2 (07) e283-e284
• 9 Nelson G, Buzko O, Patricia S, Niazi K, Rabizadeh S, Soon-Shiong P. Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the 1 combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational 2 change greater than N501Y mutant alone, potentially resulting in an escape mutant 3 4. bioRxiv [Internet]. Accessed May 17, 2021 at: https://doi.org/10.1101/2021.01.13.426558
• 10 Li B, Deng A, Li K. et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. medRxiv [Internet]. Accessed June 20, 2022 at: http://medrxiv.org/content/early/2021/07/23/2021.07.07.21260122.abstract
• 11 Wu F, Zhao S, Yu B. et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579 (7798): 265-269